GE HealthCare Q4 revenue $5.2B (+5% organic); FY24 guided adj EPS $4.20-$4.35

GE HealthCare Technologies Inc.

2023-FY EPS reported $3.03 revenue$19,552,000,000

Q4 revenue $5.2B (+5% organic YoY); net income $403M, adj EPS $1.18; adj EBIT margin 16.1%.
Full-year 2023 revenue $19.6B (+8% organic); adj EPS $3.93; operating cash flow $2.1B.
Segment: Imaging +4%, Ultrasound -2%, Patient Care +4%, Pharma Diagnostics +23% organic.
FY2024 guidance: organic rev growth ~4%; adj EBIT margin 15.6%-15.9%; adj EPS $4.20-$4.35; FCF ~$1.8B.
Repaid $850M debt in Q4 and $150M in Jan 2024; announced agreement to acquire MIM Software (no terms disclosed).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

GE HealthCare Technologies Inc. reported fourth quarter and fiscal year ended December 31, 2023 results: revenue $5.2 billion, net income $403 million. Guidance initiated.

Period: fourth quarter and fiscal year ended December 31, 2023
Revenue: $5.2 billion
Net income: $403 million
Guidance: initiated
Result: reported results

Exact text from the filing

growth. We’re confident heading into 2024 amid the backdrop of an improved capital equipment landscape.” Fourth Quarter 2023 Total Company Financial Performance • Revenues of $5.2 billion increased 5% on both a reported and Organic* basis year-over-year, driven by price and volume. • Total company book-to-bill was strong at 1.05 times, defined as Total orders

View on SEC.gov

Browse all earnings releases →

GE HealthCare Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001932393-24-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.